Related Experiment Videos
Improving cardiovascular risk stratification: the case for redefining microalbuminuria
Giovanna Leoncini1, Elena Ratto, Francesca Viazzi
1Department of Internal Medicine and Cardionephrology, Azienda Universitaria Ospedale San Martino, University of Genoa, Genoa - Italy.
Journal of Nephrology
|December 6, 2007
Summary
Microalbuminuria, a marker of kidney damage, strongly predicts cardiovascular events in hypertensive patients. Early detection and reduction of microalbuminuria can significantly improve treatment and reduce cardiovascular risk.
Area of Science:
- Nephrology
- Cardiology
- Hypertension Management
Background:
- Antihypertensive treatment cost-effectiveness rises with global cardiovascular risk burden.
- Accurate, inexpensive methods to identify high-risk patients are needed.
- Microalbuminuria is linked to hypertensive organ damage and predicts cardiovascular/cerebrovascular events.
Purpose of the Study:
- To highlight the significance of microalbuminuria in cardiovascular risk assessment.
- To emphasize the linear relationship between albuminuria and cardiovascular risk.
- To advocate for routine microalbuminuria screening in primary hypertension.
Main Methods:
- Review of epidemiological studies and clinical data on microalbuminuria.
- Analysis of the association between microalbuminuria and cardiovascular/cerebrovascular events.
- Evaluation of the impact of antihypertensive treatment on albuminuria and cardiovascular risk.
Main Results:
- Microalbuminuria is a strong, independent predictor of cardiovascular and cerebrovascular events.
- Cardiovascular risk increases linearly with urinary albumin excretion, without a clear threshold.
- Reduced albuminuria correlates with decreased cardiovascular risk under antihypertensive therapy.
Conclusions:
- Routine screening for microalbuminuria can enhance cardiovascular risk evaluation in hypertensive patients.
- Monitoring microalbuminuria aids in optimizing antihypertensive treatment strategies.
- Microalbuminuria serves as a critical biomarker for managing hypertension and preventing cardiovascular disease.
Related Concept Videos
01:28Diabetic Nephropathy
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
01:26Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
01:25Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate
The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
01:24Nephrotic Syndrome I : Introduction
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...